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Abstract
Background: Chronic exposure to arsenic is associated with cancer and hypertension. Growing evidence suggests
that altered methylation in long interspersed nuclear element-1 (LINE-1) is involved in many types of disorders,
including cardiovascular disease. Here we evaluated the association between arsenic exposure and LINE-1
methylation levels, especially in relation to blood pressure (BP).
Methods: A total of 236 subjects (175 from arsenic-endemic areas and 61 from a non-endemic area) in rural
Bangladesh were recruited. The subjects’ arsenic exposure levels (i.e., drinking water, hair and nail arsenic
concentrations) were measured by inductively coupled plasma mass spectroscopy. The subjects’ LINE-1 methylation
levels were determined by pyrosequencing.
Results: The average LINE-1 methylation levels of the subjects living in the arsenic-endemic areas were significantly
(p < 0.01) lower than those of the subjects living in the non-endemic area. In a sex-stratified analysis, the arsenic
exposure levels in female but not male subjects showed a significant inverse association with LINE-1 methylation
levels before (water arsenic: p < 0.01, hair arsenic: p < 0.05, nail arsenic: p < 0.001) and after (water arsenic: p < 0.01,
hair arsenic: p < 0.05, nail arsenic: p < 0.001) adjustment for age, body mass index and smoking. Analyses examining
interactions among arsenic levels, BP and LINE-1 methylation showed that arsenic-related elevated levels of BP were
associated with LINE-1 hypomethylation.
Conclusions: Our findings demonstrated that chronic exposure to arsenic was inversely associated with LINE-1
methylation levels in blood leukocyte DNA and this was more pronounced in females than males; in addition, the
decreased levels of LINE-1 methylation might be involved in the arsenic-induced elevation of BP.
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Background
Arsenic is a potent environmental pollutant and a class I
human carcinogen. Chronic exposure to arsenic is a
major threat to the public health in many countries,
including Bangladesh. Chronic exposure to arsenic has
been associated with several neoplastic and non-
neoplastic diseases [1–3]. It is estimated that approx.
80–100 million people in Bangladesh are at risk of
arsenic toxicity because they are consuming arsenic
through drinking water at concentrations greater than
the permissive limit (<10 μg/L) set by the World Health
Organization (WHO). The arsenic crisis in Bangladesh
has been described as the largest mass poisoning of a
population in history [4].
Health outcomes of chronic exposure to arsenic are
influenced by several genetic and non-genetic factors.
The recent development of fine and robust epigenetic
techniques and the growing evidence that supports the
involvement of epigenetic modifications in cancer and
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other diseases have created great interest in potential
epigenetic biomarkers of arsenic-related diseases.
Epigenetic changes, especially changes in DNA methyla-
tion have been reported to be implicated in the
pathogenesis of many diseases [5–9].
DNA methylation is a chemical modification of the gen-
ome that involves the covalent addition of a methyl group
(mainly to cytosine residues located in CpG dinucleo-
tides), which converts cytosine to 5-methyl cytosine. Most
of the methylation of CpG islands in mammalian genomes
is found in transposon elements that include DNA trans-
posons, retrotransposons and endogenous retroviruses.
Sequences of these transposable elements may interfere
with the regulation of gene expression and genome struc-
ture by means of insertions, deletions, and inversions and
the translocations of genomic sequences. However, it is
believed that transposon activities are decreased by high
levels of CpG methylation in transposable elements, which
effectively silences these repetitive regions [10, 11].
Long interspersed nuclear element-1 (LINE-1) is a
member of LINE family of non-long-terminal retrotran-
sposons, and it is the most abundant retrotransposon
found in the human genome, accounting for 20% of the
human genome. Growing evidence suggests that
hypomethylation in repetitive sequences of DNA such as
LINE-1and ALU is associated with various pathophysio-
logical conditions including cardiovascular disease
(CVD) [5, 12–17]. Elevated blood pressure (BP) or
hypertension is a potent risk factor for CVD, which is
the main cause of mortality worldwide. We and other
groups have shown that chronic exposure to arsenic is
associated with hypertension and circulating biomarkers
of CVD [18, 19].
Several population-based studies have identified a link
between arsenic exposure and global methylation status;
however, the results of these studies are not consistent
[14, 20–32]. Most of the previous studies did not show
the pathophysiological relevance of the arsenic
exposure-related altered DNA methylation status, and
thus the pathophysiological consequences of arsenic-
related changes in the DNA methylation status have
remained poorly understood. The main objective of this
study was to explore the association between arsenic
exposure and LINE-1 methylation levels recruiting
human subjects from arsenic-endemic and non-endemic
areas in rural Bangladesh. We also wished to examine
whether the altered levels of LINE-1 methylation were
linked to arsenic-related BP.
Methods
Study areas and subjects
Ethical permission was obtained from The University of
Rajshahi, Institute of Biological Sciences, Bangladesh
(#32/320-IAMEBBC/IBSc) and National Institute for
Environmental Studies in Japan (#2013-2R). The human
subjects who participated in this study gave their written
consent. The arsenic-endemic and non-endemic areas and
study subjects were selected as described [18, 33–38].
Arsenic-endemic study areas were selected from the
north-west region of Bangladesh that included Marua in
Jessore, Dutpatila, Jajri, Vultie and Kestopur in Chuadanga
and Bheramara in Kushtia districts. Chowkoli, a village in
Naogaon district with no history of arsenic contamination
was selected as the non-endemic area. Adults (18–60
years old) who had lived for at least the last 5 years in the
arsenic-endemic or non-endemic areas were recruited.
We attempted to match as much as possible the age,
sex and socioeconomic parameters of the arsenic-
endemic and non-endemic subjects. The ratio of en-
demic and non-endemic subjects was approx. 3:1, and
the male-to-female ratios in both the endemic and non-
endemic areas were approx. 1:1. The subjects in both
the arsenic-endemic and non-endemic areas were vil-
lagers, and the socioeconomic parameters such as occu-
pation, monthly income and education levels were very
closely matched among the areas. The subjects were
asked to convene at a convenient location in their
respective areas (irrespective of the visible presence of
skin symptoms) for enrollment and initial screening pur-
poses. Many people in the arsenic-endemic areas were
found to have skin lesions such as melanosis, hyperkera-
tosis and hard patches on the palms of the hand and
soles of the feet. The individuals who did exhibit symp-
toms were first identified by a physician, and were then
confirmed by a dermatologist. The physician carefully
examined various parts of the body to confirm the pres-
ence of skin lesions caused by exposure to arsenic.
Pregnant and lactating women, individuals who were
hepatitis B-positive, and individuals with a history of drug
addiction, chronic alcoholism, prescription for hepatotoxic
or antihypertensive medication, malaria, kala azar (leish-
maniasis), or hepatic, renal or cardiac diseases were
excluded from the study. An interview of each subject was
carried out by the trained members of our research team
who visited each household and used a standard question-
naire. Information obtained from the interview included
the sources of water for drinking and daily household
uses, water consumption history, socioeconomic status,
occupation, food habit, cigarette smoking habit, alcohol
intake, personal and family medical histories, history of
diseases, physiological complications, previous physician’s
reports, and body mass index (BMI).
Water collection and arsenic analysis
Water samples were collected from the tube wells which
the subjects used as a primary source of drinking water,
as described [33]. The total arsenic concentration in
water samples was determined by inductively coupled
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plasma mass spectroscopy (ICP-MS) after the addition
of a solution of yttrium (10 ppb in 1.0% nitric acid) as
an internal standard for the ICP-MS analysis. The
accuracy of the ICP-MS determination of the water ar-
senic concentrations was confirmed by using ‘River
water’(NMIJ CRM 7202-a No.347; National Institute of
Advanced Industrial Science and Technology, Japan) as
a certified reference material (CRM). The average value
(mean ± SD) of arsenic in the ‘River water’ determined
in triplicate by an ICP-MS analysis was 1.06 ± 0.04 μg/L
(reference value, 1.18 μg/L).
Hair and nail collections and arsenic analysis
Hair and toe nails of the subjects were collected and
washed as described [33]. The washed samples were
allowed to dry at 60 °C overnight and then digested with
concentrated nitric acid using a hot plate at 70 °C for
15 min and 115 °C for 15 min. After cooling, the samples
were diluted with 1.0% nitric acid containing yttrium
(10 ppb). The concentrations of arsenic and yttrium in
these samples were determined by ICP-MS (HP-4500,
Agilent Technologies, Kanagawa, Japan). All samples were
determined in triplicate and the average values were used.
The accuracy of the arsenic measurement was verified by
using the CRM“human hair” (GBW09101, Shanghai
Institute of Nuclear Research Academia Sinica, China).
The average value of arsenic in “human hair” determined
in triplicate followed by an ICP-MS analysis was 0.61 ±
0.12 μg/g (reference value, 0.59 μg/g).
BP measurement
The WHO standard protocol for measuring BP was
used. After the subject had rested for ≥20 min, both
systolic and diastolic blood pressures (SBP and DBP)
were measured three times with a mercury sphygmo-
manometer with the subject sitting. SBP and DBP were
defined at the first-and fifth-phase Korotkoff sounds, re-
spectively. The average of three measurements was used
for the analysis. Hypertension was defined as an SBP
value of ≥140 mmHg and a DBP value of ≥90 mmHg on
three repeated measurements.
Blood collection and extraction of DNA
Peripheral blood was collected from each subject as
described [33]. Fasting blood samples (5–7 mL) were
collected in EDTA-containing blood collection tubes
from each individual by venipuncture as described [18,
37]. From the EDTA-treated blood, 100 μl was taken
and DNA was extracted with the use of a DNeasy Blood
and Tissue kit (Qiagen, Valencia, CA, USA) according to
the manufacturer’s recommendations. Extracted DNA
was kept at −20 °C. Because whole blood DNA was pre-
dominantly derived from leukocytes, we refer to the
whole blood DNA as leukocyte DNA here in.
Measurement of LINE-1 DNA methylation
Genomic DNA was digested with EcoRI. The bisulfite
conversion of DNA was carried out using the EZ-96
DNA Methylation-Gold™ kit (Zymo Research, Irvine,
CA) according to the manufacturer’s recommendations.
We conducted a polymerase chain reaction (PCR)
amplification of bisulfite-modified DNA using a set of
forward primer 5′-TTTTGAGTTAGGTGTGGGATATA
-3′ and reverse biotinylatedprimers5′-Biotin-AAAATCA
AAAAATTCCCTTTC-3′ as reported [24]. The condi-
tions were as follows: 95 °C for 5 min, and then 50 cycles
of 95 °C for 30s, 50 °C for 30s, and 72 °C for 45 s, and
finally 72 °C for 5 min.
To measure the methylation level of each of the first
three CpG sites next to the pyrosequencing primer, we
performed sequencing of the PCR product by pyrose-
quencing using the PyroMark Q96 ID System (Qiagen)
according to the manufacturer’s recommendations. The
pyrosequencing primer for LINE-1 was 5′-GGGTGGGA
GTGAT-3′. We extracted the methylation level at each
CpG site by using PyroMark Q96 software, ver.2.5.8
(Qiagen). The average methylation level of the first
three LINE-1 CpG sites was used as the LINE-1
methylation level.
Statistical analyses
The statistical analyses were conducted with the Statis-
tical Package for the Social Sciences (SPSS ver. 21.0,
SPSS, Chicago, IL). A p-value <0.05 was considered sig-
nificant. The normality of the distribution of variables
was verified by a Q–Q plot. Because of the skewed
distributions of the arsenic exposure metrics, we used
log-transformed (natural log) values for the statistical
analysis. The differences in descriptive characteristics,
arsenic exposure levels and other characteristics between
the residents of the arsenic-endemic and non-endemic
areas were analyzed by an independent sample t-test for
continuous variables and the Chi-square test for categor-
ical variables. A nonparametric Kruskal-Wallis test was
used to analyze the differences in inter-quartile range
(IQR) between the subjects in the arsenic-endemic and
non-endemic areas.
We performed a multiple linear regression analysis to
examine the effects of age, sex, BMI and smoking on the
association between arsenic exposure metrics and LINE-
1 methylation levels. To determine the association and
the effects of the variables, we obtained the unadjusted
R2 and adjusted R2 values. ΔR2 values were calculated by
subtracting the unadjusted R2 from the adjusted R2.
Finally, we performed multivariate regression analyses to
examine the interactions between arsenic exposure, BP
and LINE-1 methylation, and to assess the effects of age,
sex, BMI and smoking on the associations of arsenic ex-
posure and LINE-1 methylation levels with BP.
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Results
Table 1 summarizes the descriptive characteristics of the
subjects in the arsenic-endemic (n = 175) and non-
endemic areas (n = 61). Of the 236 subjects, 125 were
males and 111 were females. Since we attempted to
match the subjects’ age, sex and socioeconomic parame-
ters (occupation, monthly income and education)
between the residents of the arsenic-endemic and non-
endemic areas, no significant differences were observed
in those parameters between the two groups. Most of
the male subjects were farmers, and most of the female
subjects were housewives. We did not identify any
female smokers, as generally Bangladeshi women do not
smoke. None of the subjects drank alcohol because of
the social and religious restrictions on alcohol in
Bangladesh.
Table 2 shows the arsenic exposure levels and other
characteristic of the subjects. The average concentra-
tions of arsenic in the drinking water, hair and nails of
the subjects in the arsenic-endemic areas were
approx.70, 8 and 6 times higher, respectively, than those
of the subjects in the non-endemic area. The compari-
son of the arsenic exposure levels between the males
and females living in the arsenic-endemic areas showed
that the average concentrations of arsenic in the drink-
ing water, hair and nails were slightly higher in the
females than the males, although the differences were
not significant. Approximately 75% of the subjects in the
arsenic-endemic areas showed skin symptoms, whereas
none of the subjects in the non-endemic areas did.
The levels of DBP and SBP of the subjects in the
arsenic-endemic areas were significantly (p < 0.001)
higher than those of the subjects in the non-endemic
area, as we reported [18, 35, 37]. Accordingly, the per-
centage of hypertensive subjects was also higher in the
arsenic-endemic areas compared to the non-endemic
area. When the levels of DBP and SBP and the percent-
age of hypertensive subjects were compared between
males and females within the arsenic endemic areas, the
SBP levels and the percentage of hypertensive patients
were significantly higher in the females compared to the
males. The differences in DBP and SBP between the
arsenic-endemic and non-endemic areas were much
greater in the females than the males.
As shown in Table 2, no significant differences in
LINE-1 methylation levels were observed in the male
subjects between those living in the arsenic-endemic
areas and the non-endemic area. In the female subjects,
however, the average levels of LINE-1 methylation were
64.23 ± 2.38 and 65.92 ± 1.66 in the arsenic-endemic and
non-endemic areas respectively, and the difference was
significant (p < 0.01). These data suggest that the associ-
ation between arsenic exposure and LINE-1 hypomethy-
lation is more pronounced in females than males.
Table 3 shows the results of the multiple linear
regression analyses regarding the association between ar-
senic exposure and LINE-1 methylation levels. For all
subjects, the non-adjusted associations between arsenic
exposure and LINE-1 methylation were significantly nega-
tive (R2 = 0.033,95% CI = −0.241, −0.043, p < 0.01 for water
arsenic; R2 = 0.019,95% CI = −0.378, −0.014, p < 0.05 for
hair arsenic; and R2 = 0.054,95% CI = −0.595,−0.179, p <
0.001for nail arsenic). After adjustment for age, BMI and
smoking, the associations between arsenic exposure and
LINE-1 methylation levels remained significant (R2 =
0.057,95% CI = −0.238, −0.038, p < 0.01 for water ar-
senic; R2 = 0.045,95% CI = −0.382, −0.014, p < 0.05 for
Table 1 Demographic characteristics of the study populations
in arsenic-endemic and non-endemic areas
Parameter All Non-endemic Arsenic-endemic p-value
Subjects (n) 236 61 175
Sex (n)
Male 125 33 92
Female 111 28 83
Age (yrs.)a 35.69 ± 10.13 33.92 ± 9.18 36.30 ± 10.40 0.114*
IQR 28.00–43.74 27.00–40.00 28.00–45.00 0.079‡
BMI (kg/m2)a 20.94 ± 3.57 20.76 ± 2.77 21.00 ± 3.82 0.655*
IQR 18.54–22.57 18.71–22.51 18.37–23.00 0.922‡
Occupation [n, (%)]
Male 0.795†
Farmers 97 (77.60) 24 (72.70) 73 (79.30)
Business 5 (4.00) 1 (3.00) 4 (4.30)
Students 5 (4.00) 2 (6.10) 3 (3.30)
Worker 10 (8.00) 4 (12.30) 6 (6.50)
+Others 8 (6.40) 2 (6.10) 6 (6.50)
Female 0.194†
Housewives 105 (94.60) 25 (89.3) 80 (96.40)
Students 4 (3.60) 2 (7.10) 2 (2.40)
‡Others 2 (1.80) 1 (3.60) 1 (1.20)
Education [n, (%)]
No formal education 142 (60.20) 31 (50.82) 111 (63.43) 0.138†
Primary 66 (28.00) 18 (29.51) 48 (27.43)
Secondary 19 (8.10) 8 (13.11) 11 (6.30)
Higher 9 (3.80) 4 (6.60) 5 (2.90)
Income/month
(US$)a
23.45 ± 10.41 22.67 ± 8.89 23.72 ± 10.89 0.457*
Smoking in male [n, (%)]
Yes 43 (34.40) 13 (39.40) 30 (32.60) 0.309†
No 82 (65.60) 20 (60.60) 62 (67.40)
Alcohol intake – – – –
BMI was calculated as body weight (kg) divided by height squared (m2)
Abbreviation: As arsenic, BMI body mass index, IQR inter-quartile range
amean ± SD
*p-,‡p-and†p-values were obtained by an independent sample t-test,
Kruskal-Wallis test and Chi-square test, respectively. +Others included village
doctor, security guard, banker and worker. ‡Others included farmer
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Table 2 Arsenic exposure levels and other characteristics of the subjects in the arsenic-endemic and non-endemic areas
Parameter All Non-endemic Arsenic-endemic p-value
Subjects (n) 236 61 175
Drinking water As (μg/L)b
Total subjects 17.76 (15.16) 0.76 (5.49) 53.39 (7.90) <0.001*
Males 13.28 (19.90) 0.60 (4.96) 40.22 (9.02) <0.001*
Females 24.66 (13.97) 0.98 (6.10) 73.09 (6.52) <0.001*
p-value (between male & female groups) 0.081* 0.269* 0.056*
Hair As (μg/g)b
Total subjects 1.28 (4.43) 0.25 (2.38) 2.08 (3.54) <0.001*
Males 1.08 (4.80) 0.19 (2.15) 1.99 (3.70) <0.001*
Females 1.39 (3.99) 0.36 (2.40) 2.20 (3.38) <0.001*
p-value (between male & female groups) 0.191* <0.01* 0.604*
Nail As (μg/g)b
Total subjects 3.40 (3.53) 0.96 (2.43) 5.29 (2.96) <0.001*
Males 3.19 (3.41) 1.05 (2.32) 4.73 (3.00) <0.001*
Females 3.67 (3.78) 0.85 (2.58) 5.98 (2.98) <0.001*
p-value (between male & female groups) 0.403* 0.367* 0.155*
Skin symptoms [n, (%)]
(+) symptom 132 (55.90) 0 (0.0) 132 (75.40) <0.001†
(−) symptom 104 (44.10) 61 (100.0) 43 (24.60)
DBP (mm Hg)a
Total subjects 77.11 ± 11.84 71.97 ± 9.89 78.90 ± 11.96 <0.001*
Males 76.73 ± 10.51 73.33 ± 8.26 77.95 ± 10.99 <0.05*
Females 77.54 ± 13.21 70.36 ± 11.46 79.96 ± 12.93 <0.01*
p-value (between male & female groups) 0.608* 0.245* 0.269*
SBP (mm Hg)a
Total subjects 118.72 ± 18.01 111.18 ± 14.22 121.35 ± 18.48 <0.001*
Males 116.56 ± 14.83 112.88 ± 10.91 117.88 ± 15.83 0.097*
Females 121.16 ± 20.83 109.18 ± 17.30 125.20 ± 20.45 <0.001*
p-value (between male & female groups) 0.055* 0.334* <0.01*
Hypertension [n, (%)]
Total subjects
Yes 32 (13.60) 3 (4.90) 29 (16.60) <0.05†
No 204 (86.40) 58 (95.10) 146 (83.40)
Males
Yes 10 (8.00) 0 (0.0) 10 (10.90) <0.05†
No 115 (92.00) 33 (100.0) 82 (89.10)
Females
Yes 22 (19.80) 3 (10.70) 19 (22.90) 0.162†
No 89 (80.20) 25 (89.30) 64 (77.10)
p-value (between male & female groups) <0.01† 0.054† <0.05†
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hair arsenic; and R2 = 0.079,95% CI = −0.591, −0.175, p
< 0.001 for nail arsenic).
Since we observed a sex-based difference in LINE-1
methylation (Table 2), we performed sex-specific ana-
lyses. Intriguingly, we found that the drinking water, hair
and nail arsenic concentrations of the female subjects
showed significant inverse associations with LINE-1
methylation both before (R2 = 0.079,95% CI = −0.410,
−0.088, p < 0.01 for water arsenic;R2 = 0.043,95% CI =
−0.662,−0.038, p < 0.05 for hair arsenic; and R2 =
0.100,95% CI = −0.862, −0.236, p < 0.01 for nail ar-
senic) and after (R2 = 0.085,95% CI = −0.407, −0.081,
p < 0.01 for water arsenic;R2 = 0.053,95% CI = −0.664,
−0.037, p < 0.05 for hair arsenic; and R2 = 0.106,95%
CI = −0.858, −0.224, p < 0.01 for nail arsenic) adjust-
ment for covariates. No significant associations were
observed in the male subjects.
Table 4 shows the associations of arsenic exposure
with BP with and without adjustment for LINE-1 methy-
lation levels through multivariate linear regression ana-
lyses. In all subjects and in the female subjects, the
water, hair and nail arsenic concentrations showed
significant associations with DBP and SBP without
adjustment for LINE-1 methylation. However, after
adjustment with LINE-1 methylation, the associations
between arsenic exposure and DBP and SBP were weak-
ened in all subjects, and the associations completely
disappeared in the female subjects.
Additional file 1 shows the associations between the
arsenic exposure metrics and LINE-1 methylation levels
with BP after adjustment for age, sex, BMI and smoking.
The adjusted association between arsenic exposure levels
and BP, and that between LINE-1 methylation levels and
BP were found to be significant.
Table 2 Arsenic exposure levels and other characteristics of the subjects in the arsenic-endemic and non-endemic areas (Continued)
LINE-1 Methylation level (%)a
Total subjects 64.94 ± 2.12 65.67 ± 1.99 64.69 ± 2.12 <0.01*
Males 65.21 ± 1.91 65.46 ± 2.24 65.12 ± 1.78 0.430*
Females 64.65 ± 2.33 65.92 ± 1.66 64.23 ± 2.38 <0.01*
p-value (between male & female groups) <0.05* 0.372* <0.01*
aMean ± SD. bGeometric mean (GSD) for log-transformed value
*p- and †p-values were obtained by independent sample t-test and Chi-square test, respectively
Table 3 Associations of arsenic exposure metrics with LINE-1 methylation levels
As-
exposure
Dependent variable LINE-1 methylation (%)
All subjectsa Malesb Femalesc
Unadjusted Adjusted Unadjusted Adjusted Unadjusted Adjusted
Water As
R2 0.033 0.057 0.003 0.018 0.079 0.085
ΔR2 0.024 0.015 0.006
95% CI −0.241,−0.043 −0.238,−0.038 −0.161, 0.085 −0.178,0.076 −0.410,−0.088 −0.407,−0.081
p-value <0.01 <0.01 0.539 0.428 <0.01 <0.01
Hair As
R2 0.019 0.045 0.003 0.019 0.043 0.053
ΔR2 0.009 0.016 0.010
95% CI −0.378,−0.014 −0.382,−0.014 −0.282,0.150 −0.318,0.129 −0.662,−0.038 −0.664,−0.037
p-value <0.05 <0.05 0.545 0.406 <0.05 <0.05
Nail As
R2 0.054 0.079 0.016 0.031 0.100 0.106
ΔR2 0.025 0.015 0.006
95% CI −0.595,−0.179 −0.591,−0.175 −0.469,0.079 −0.490,0.066 −0.862,−0.236 −0.858,−0.224
p-value <0.001 <0.001 0.162 0.134 <0.01 <0.01
Log-transformed values of arsenic concentrations were used
aAdjusted for age, sex, BMI and smoking status
bAdjusted for age, BMI and smoking status
cAdjusted for age and BMI
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Discussion
In this study, we explored the association between arsenic
exposure, as measured by drinking water, hair and nail ar-
senic concentrations, and LINE-1 methylation levels
through a cross sectional study recruiting human subjects
from arsenic-endemic and non-endemic areas in
Bangladesh. We also examined whether the altered
methylation levels were associated to arsenic exposure-
related elevated levels of BP. The results demonstrated
that the LINE-1 methylation levels were significantly
lower among individuals living in arsenic-endemic areas
compared to those in non-endemic areas (Table 2). The
drinking water, hair and nail arsenic concentrations of the
female subjects showed significant negative associations
with LINE-1 methylation levels (Table 3). On the contrary,
no significant associations of arsenic exposure metrics
with LINE-1 methylation levels were observed in the
males, suggesting that the apparent associations between
arsenic exposure and LINE-1 hypomethylation in all sub-
jects may be a reflection of the significant association in
females (Table 3). In addition, the arsenic exposure met-
rics in the females showed significant positive associations
with BP. Intriguingly, interaction analyses revealed that
the arsenic-related elevated levels of BP were correlated
with LINE-1 hypomethylation levels (Table 4).
A good number of studies using cell lines and experi-
mental animals have been conducted to evaluate the ef-
fects of arsenic exposure on global DNA methylation
[39–48]. Human studies have also revealed the effects of
arsenic exposure on DNA methylation status, but the
specific alterations are not consistently observed. By
conducting a methylation incorporation assay, Pilsner et
al. [24] showed that the plasma arsenic and urinary ar-
senic levels of their subjects were negatively correlated
with the extent of [3H]-methyl incorporation, suggesting
that arsenic exposure was positively associated genomic
methylation levels of blood leukocyte DNA. In another
study, the same group (2009) [25] reported that arsenic-
exposed individuals with skin lesions had lower levels of
methylation in DNA than the arsenic-exposed individ-
uals without skin lesions. Majumdar et al. [21] observed
an association between genome-wide hypermethylation
and drinking water arsenic levels, in a population of only
64 individuals. In a gene-specific analysis, Hossain et al.
[30] found that urinary arsenic was positively associated
with the methylation of a tumor suppressor gene, p16.
In the same study, they did not observed an association
between urinary arsenic and LINE-1 methylation. In a
study of neonates in Bangladesh, Kile et al. [31] identi-
fied a positive association between maternal urinary total
arsenic and LINE-1 methylation levels in both the
mother and newborns. Pilsner et al. [29] obtained similar
results in their study of mother-newborn pairs in
Bangladesh; however, in their sex-specific analyses, the
associations between arsenic exposures and ALU, LINE-
1 and LUMA were positive among the male newborns
but negative among the female newborns (although the
results were not significant). In contrast, Broberg et al.
[32] reported that early prenatal arsenic exposure ap-
pears to decrease DNA methylation in boys but not in
girls. It is not yet clear how long the alteration in the
methylation status in DNA is stable or what the conse-
quences of the neonatal alteration of DNA methylation
will be in later life. Niedzwiecki et al. [23] reported that
arsenic exposure was not associated with global 5-
methyl cytosine (MC) levels or 5-hydroxyl methyl cyto-
sine (hmC) levels in their complete subject population,
but in their sex-specific analyses, they observed a posi-
tive association between arsenic exposure and global 5-
hmC levels in the males and a negative association in
the females. The female-specific LINE-1 hypomethyla-
tion revealed in our present study partially agrees with
the findings of Niedzwiecki et al.’s study. The discrepan-
cies in the results from one study to another may be due
to differences in arsenic doses, exposure times, the re-
petitive elements of DNA targeted for measuring global
methylation levels, and nutritional or other confounding
factors influencing the effects of arsenic exposure. Most
of the previous studies did not demonstrate the bio-
logical consequences of the relationships between ar-
senic exposure and changes in DNA methylation, and
thus there are great uncertainties regarding the patho-
physiological consequences of the arsenic-induced alter-
ation of methylation status in DNA.
Against this background, our present data demonstrat-
ing an association between arsenic exposure and re-
duced levels of LINE-1 methylation and their
interactions with elevated levels of BP are noteworthy.
Recent studies have shown a link between the decreased
methylation levels in global and specific DNAs with
CVD-related events [5, 49]. Castro et al. [50] reported
lower DNA methylation levels in peripheral blood leuko-
cytes from patients with atherosclerotic disease. It was
also reported that a lower blood LINE-1 methylation
level is a predictive factor for the incidences and mortal-
ities of ischemic heart disease and stroke [5]. Bellavia et
al. [51] showed an association between particulate-
matter-mediated hypomethylation and BP. Similar to the
results of our previous research [18, 35, 37], in the
present study we also observed that the average levels of
BP and the percentage of hypertensive patients were
higher in the arsenic-endemic areas compared to the
non-endemic area, and the average levels of SBP and the
percentage of hypertensive patients were higher in the
females than the males in the arsenic-endemic areas
(Table 2).
Intriguingly, in our multivariate regression analysis,
the significance of the associations of arsenic exposure
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metrics with DBP and SBP disappeared in the female
subjects after the adjustment for LINE-1 methylation
levels, indicating that LINE-1 hypomethylation might be
involved in an arsenic-related elevation of BP (Table 4).
These results are in line with those of studies that
showed a link between LINE-1 hypomethylation and
CVD, especially hypertension [16, 50, 51]. It should be
noted here that sex differences are also known to be
present in other diseases caused by chronic exposure to
arsenic. For example, women have been found to have
higher risks of arsenic-related kidney, lung and bladder
cancers as well as diabetes compared to men [14, 52–54].
The higher susceptibility of arsenic-exposed females to hy-
pomethylation in DNA observed in the present study may
also be associated with the higher incidences of those dis-
eases in females compared to males.
Demographic and lifestyle characteristics such as age,
sex, BMI, smoking, and alcohol consumption may be
associated with global DNA methylation. However, the
reports- regarding the effects of these characteristics are
inconsistent [17, 26, 55]. In our regression analyses, we
did not consider alcohol consumption as a variable be-
cause none of the subjects admitted to drinking alcohol.
Before and after the adjustment for covariates (age, sex,
BMI and smoking), significance levels of the associations
between arsenic exposure and LINE-1 hypomethylation
were not considerably different in the females, which in-
dicated that age, sex and BMI had little or almost no
effects on the associations. These results are consistent
with those reported by Cash et al. [56]. In our study, the
majority (65.60%) of the male subjects were not smokers
and no females were smokers. In the selection process of
the present study, we excluded older individuals
(>60 years old). The narrow ranges of age (IQR: 28–
43.70 years) and BMI (IQR: 18.25–22.57) and the
smaller number of smokers may explain why we did not
observe any confounding effects of those variables on
LINE-1 methylation status.
Since a variety of factors are involved in the devel-
opment of hypertension, it seems unlikely that the
epigenetic regulation of global genes is a sole factor
causing hypertension in individuals living in arsenic-
endemic areas. To eliminate the confounding effects
of age, sex, BMI, and smoking on the associations of
arsenic exposure and LINE-1 methylation with BP,
we performed further regression analyses (Additional
file 1), and we found that arsenic exposure and
LINE-1 hypomethylation retained their significant
association with BP after the adjustment for those
variables. These results suggest that arsenic exposure
and LINE-1 hypomethylation may be important con-
tributors to the elevation of BP.
It remains unknown why females are more susceptible
to arsenic-induced LINE-1 hypomethylation than males.
One possibility is that higher levels and more consistent
exposure to arsenic through drinking water in females
than males may make females more susceptible to
LINE-1 hypomethylation. Our female subjects (most of
whom are housewives) may depend more on arsenic-
contaminated tube-well water at home than the males
(most of whom are farmers), who work outside their
homes. The average concentrations of drinking water in
arsenic-endemic areas were higher in the females than
males, although the significance of the difference was
borderline (p = 0.056) (Table 2). However, this result
may not be enough to draw a conclusion, because the
differences in hair and nail arsenic concentrations—
which are more important indicators of the body’s accu-
mulation of arsenic—were not significant between the
males and females. Another possible explanation for
female susceptibility to LINE-1 hypomethylation is the
effects of sex hormones. Cell line experiments demon-
strated that the methylation levels of LINE-1 were
decreased by treatment with estradiol but not with
dihydrotestosterone [57]. Arsenic exposure has been
reported to have endocrine-disruptive effects [58, 59],
and it may thus be likely that arsenic causes hypomethy-
lation through its endocrine-disrupting activity.
The strength of the present study was that we exam-
ined three types of exposure metrics (drinking water,
hair and nail arsenic concentrations), and all indicators
including external (drinking water) and internal (hair
and nail) exposure metrics showed significant negative
associations with the levels of LINE-1 methylation in the
female subjects (Tables 3). Hypomethylation in the
LINE-1 sequence across the three exposure metrics may
exclude the potential bias in the observed associations.
However, our study has some limitations that should
be carefully evaluated. First, although we detected
significant differences in hypomethylation in LINE-1
between the residents of the arsenic-endemic and non-
endemic areas, the absolute values were very small. The
differences in LINE-1 methylation levels in the females
were within 2% between the arsenic-endemic and non-
endemic areas (Tables 2). Similar to our results, however,
small but significant differences in global DNA methylation
were reported to be associated with the risk of head and
neck squamous cell carcinoma (74.7% in cases vs. 75.3% in
controls [60] and Alzheimer disease (AD);AD: 83.6%5mC,
volunteers: 83.1% 5mC, p = 0.05) [61]. Moreover, recently
published data showed that a small reduction in LINE-1
methylation significantly increased the risk of coronary
heart disease in a Chinese population [17]. All of these re-
sults support the notion that a small difference in global
genomic DNA methylation could be involved in the patho-
genesis of several diseases including CVD.
Second, the nutritional status of our subjects which
were not considered in this study may have affected the
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levels of global DNA methylation. It was suggested that
the folate nutritional status may alter the methylation of
DNA [24]. Third, we examined the LINE-1 methylation
in blood leukocyte DNA, but it remains unclear whether
the leukocytes’ DNA reflects the effects of arsenic expos-
ure on other organs such as skin, liver, bladder, kidney,
spleen and lung. Although growing evidence has sug-
gested global DNA hypomethylation in peripheral blood
leukocytes as a biomarker for cancer and CVD, an
organ-specific DNA methylation status may be more im-
portant to understand organ-specific effects and health
outcomes caused by chronic exposure to arsenic.
Because of their wide distribution in genomic DNA,
the methylation levels of LINE-1 have been used as a
proxy for global DNA methylation status [62–64].
Methylation at LINE-1 repeats is gaining increasing at-
tention as a surrogate marker to distinguish normal
from pathological disease tissue [57]. Decreased methy-
lation of LINE-1 sequences in blood leukocyte DNA has
been documented in many human cancers and other
chronic diseases [12–16] Therefore, LINE-1 hypomethy-
lation in blood leukocyte-derived DNA caused by
chronic exposure to arsenic may be one of the potential
epigenetic mechanisms of arsenic-induced chronic dis-
eases, including hypertension.
Conclusions
Our data demonstrated that chronic exposure to arsenic
is significantly associated with global DNA hypomethyla-
tion measured in LINE-1 repeats in the blood leukocyte
DNA; this association is more pronounced in females
than males. We also observed a significant interaction of
arsenic-related elevated levels of BP with LINE-1 hypo-
methylation, which indicates the possible involvement of
LINE-1 hypomethylation in chronic arsenic exposure-
related hypertension in females. A large prospective
study is required to test these observations.
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